271560:KRXORION CORP. Analysis
Data as of 2026-03-15 - not real-time
₩129,300.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
ORION Corp. is trading at KRW 129,300, which sits just below its 20‑day SMA of 132,220 but remains above the 50‑day SMA, indicating short‑term pressure within a longer‑term uptrend. The forward P/E of roughly 10× and a DCF‑derived fair value of about KRW 180,500 imply an upside potential of nearly 19%, suggesting the stock is currently undervalued. Revenue is expanding at a solid 7% annual rate, while gross, operating and profit margins hover around 37%, 17% and 16% respectively, underscoring resilient profitability. A strong cash position (over KRW 1.1 trillion) and modest debt (≈KRW 35 billion) give the balance sheet ample flexibility. The dividend yield of 2.71% with an 18.6% payout ratio points to a sustainable income stream. Analyst consensus is a “strong buy” with a median target of KRW 151,000, reinforcing the valuation case.
Technical signals are mixed: RSI at 53.6 signals neutral momentum, while a bearish MACD histogram and declining volume hint at short‑term weakness. Nevertheless, the overall trend is flagged bullish and the sector—consumer defensive confectionery—offers relative stability. Volatility remains high at 38% over the past 30 days, but the beta of only 0.14 indicates limited sensitivity to broader market swings. The company’s exposure to South Korea and China introduces moderate geographic and regulatory considerations, yet its diversified product mix mitigates concentration risk. With these dynamics, the stock presents a balanced risk‑reward profile for investors seeking both capital appreciation and dividend income.
Technical signals are mixed: RSI at 53.6 signals neutral momentum, while a bearish MACD histogram and declining volume hint at short‑term weakness. Nevertheless, the overall trend is flagged bullish and the sector—consumer defensive confectionery—offers relative stability. Volatility remains high at 38% over the past 30 days, but the beta of only 0.14 indicates limited sensitivity to broader market swings. The company’s exposure to South Korea and China introduces moderate geographic and regulatory considerations, yet its diversified product mix mitigates concentration risk. With these dynamics, the stock presents a balanced risk‑reward profile for investors seeking both capital appreciation and dividend income.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price near 20‑day SMA resistance
- bearish MACD histogram
- declining volume
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF upside ~19%
- sustainable dividend yield
- strong cash balance
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- stable consumer defensive sector
- consistent earnings growth
- low beta and defensive profile
Key Metrics & Analysis
Financial Health
Revenue Growth7.00%
Profit Margin16.21%
P/E Ratio10.1
ROE15.41%
ROA8.41%
Debt/Equity0.93
Op. Cash Flow₩570.2B
Free Cash Flow₩327.8B
Technical Analysis
TrendBullish
RSI53.6
Support₩0.00
Resistance₩143,400.00
MA 20₩132,220.00
MA 50₩120,116.00
MA 200₩111,086.00
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88
Valuation
Fair Value₩180,504.87
Target Price₩153,315.80
Upside/Downside18.57%
GradeUndervalued
TypeBlend
Dividend Yield2.71%
Risk Assessment
Beta0.14
Volatility38.15%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.